z-logo
open-access-imgOpen Access
Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis
Author(s) -
Fernandes Samuel Raimundo,
Santos Patrícia,
Fatela Narcisa,
Baldaia Cilénia,
Tato Marinho Rui,
Proença Helena,
Ramalho Fernando,
Velosa José
Publication year - 2016
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.21994
Subject(s) - spontaneous bacterial peritonitis , calprotectin , medicine , cirrhosis , ascites , gastroenterology , gold standard (test) , decompensation , ascitic fluid , positive predicative value , predictive value , disease , inflammatory bowel disease
Background Spontaneous bacterial peritonitis ( SBP ) is a known complication of advanced cirrhosis and presents a high mortality rate. A polymorphonuclear ( PMN ) cell count >250/μl in the ascitic fluid is the current gold standard for diagnosing SBP . Aim We evaluated the accuracy of a point‐of‐care test ( POCT ) for ascitic calprotectin in diagnosing patients with SBP . Methods Eighty‐eight patients admitted with decompensation of liver cirrhosis were studied including 41 patients (46.6%) with SBP . Ascitic calprotectin was measured using a quantitative POCT developed by Bühlmann ® . Results Calprotectin levels correlated with PMN cell count and other inflammatory markers and were significantly higher in patients with SBP . An optimal cutoff of calprotectin above 1.57 μg/ml presented high sensitivity (87.8%), specificity (97.9%), and positive (97.3%) and negative (90.2%) predictive values for diagnosing SBP . Using calprotectin selectively in patients with a serum albumin‐ascites gradient above 11 g/l further increased the sensitivity and negative predictive values of the test. Conclusion Ascitic calprotectin appears to be a reliable method for diagnosing SBP in patients with liver cirrhosis. It may present an alternative to other conventional diagnostic methods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here